Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines()

CD133 is a cellular surface protein, which has been reported to be a cancer stem cell marker, and thus is considered a potential target for cancer treatment. Metformin, one of the biguanides used for the treatment of diabetes, is also known to reduce the risk of cancer development and cancer stem-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Maehara, Osamu, Ohnishi, Shunsuke, Asano, Ayaka, Suda, Goki, Natsuizaka, Mitsuteru, Nakagawa, Koji, Kobayashi, Masanobu, Sakamoto, Naoya, Takeda, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488768/
https://www.ncbi.nlm.nih.gov/pubmed/31042624
http://dx.doi.org/10.1016/j.neo.2019.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488768/
https://www.ncbi.nlm.nih.gov/pubmed/31042624
http://dx.doi.org/10.1016/j.neo.2019.03.007

Ejemplares similares